Harrow Inc (HROW)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HROW Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Harrow Inc Stock (HROW) Company Profile

Healthcare (1104)

615.733.4731

1A BURTON HILLS BLVD, NASHVILLE, CA

Prossima data di guadagno

Ultimi documenti SEC

HROW's Discussions on Twitter

Compare HROW vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HROW Harrow Inc	42.87	1.60B	272.30M	-5.14M	42.76M	-0.1635
TAK Takeda Pharmaceutical Co Adr	15.63	49.39B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	8.96	39.55B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.48	36.66B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	78.71	33.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	536.59	22.78B	3.17B	1.29B	1.01B	27.09

Harrow Inc Stock (HROW) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-11	Iniziato	Cantor Fitzgerald	Overweight
2025-06-12	Iniziato	BTIG Research	Buy
2025-06-10	Iniziato	William Blair	Outperform
2025-02-06	Iniziato	H.C. Wainwright	Buy
2024-12-04	Reiterato	B. Riley Securities	Buy
2024-04-11	Iniziato	Craig Hallum	Buy
2022-09-08	Ripresa	B. Riley Securities	Buy
2021-10-14	Ripresa	B. Riley Securities	Buy
2021-09-24	Iniziato	Aegis Capital	Buy
2021-07-02	Iniziato	Ladenburg Thalmann	Buy

Mostra tutto

Harrow Inc Borsa (HROW) Ultime notizie

Harrow Inc Azioni (HROW) Dati Finanziari

Harrow Inc (HROW)

Harrow Inc Stock (HROW) Company Profile

Compare HROW vs TAK, HLN, TEVA, ZTS, UTHR

Harrow Inc Stock (HROW) Upgrades & Downgrades

Harrow Inc Borsa (HROW) Ultime notizie

Spotlight On Harrow And 2 Other Growth Stocks With Strong Insider Backing - simplywall.st

Harrow Inc (HROW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Harrow Inc (HROW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Harrow Inc (HROW) Institutional Confidence - TradingKey

Harrow Inc (HROW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Harrow Inc (HROW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Harrow Inc (HROW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Harrow Inc (HROW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Harrow Inc (HROW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Is Harrow, Inc. (HROW) A Good Stock To Buy Now? - Yahoo Finance

HROW News | HARROW INC (NASDAQ:HROW) - ChartMill

Harrow Adds Another Piece To Ophthalmology Strategy - Benzinga

HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US - TradingView

What Harrow (HROW)'s VERKAZIA Re‑Launch in Pediatric VKC Means For Shareholders - Sahm

HROW Stock Rips Higher As Traders Digest Mixed Quarter - timothysykes.com

Analysts Are Bullish on Top Healthcare Stocks: Harrow Health (HROW), GeneDx Holdings (WGS) - The Globe and Mail

Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic - GlobeNewswire

Harrow Inc. Q1 2026 Earnings: Significant EPS Miss Triggers Stock DeclineBook Value Growth - newsline.com

HARROW INC (HROW) Stock Chart - ChartMill

What Does Cantor Fitzgerald Think About Harrow (HROW) After Cutting Its Price Target? - Insider Monkey

Harrow Health Inc stock (US4158581094): Ophthalmology player trades below analyst targets amid secto - AD HOC NEWS

Harrow Inc. (HROW) Q1 2026 Earnings: Significant Earnings Miss Despite Positive Stock ReactionPeak Earnings Alert - newsline.com

William Blair Maintains Harrow(HROW.US) With Buy Rating - Moomoo

Harrow Health Releases June 2026 Investor Presentation Update - TipRanks

Harrow files Regulation FD disclosure to furnish June 2026 corporate presentation - TradingView

Harrow (NASDAQ: HROW) posts June 2026 corporate investor presentation - Stock Titan

Top 5 Small Cap Stocks With Huge Growth Potential - Insider Monkey

Harrow Health earnings on deck: Can branded drugs offset California exit? - Investing.com Nigeria

Harrow Inc. Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesProfit Cycle Analysis - thelegaladvocate.com

Harrow Inc. (HROW) Advances 2.79% as Stock Approaches Key ResistanceLow Vol ETF - thelegaladvocate.com

Harrow Inc. (HROW) Q1 2026 Earnings: Wider-than-Expected Loss Triggers Stock RallyRevenue Per Share - thelegaladvocate.com

Harrow Inc. Q1 2026 Earnings: EPS Misses Estimates Significantly, Stock Rises Despite LossesEarnings Revision Report - newsline.com

Harrow to Present at William Blair’s 46th Annual Growth Stock Conference - GlobeNewswire

HROW Q1 2026 Earnings: EPS Misses Estimates Significantly as Company Navigates Operational ChallengesCapex Guidance - newsline.com

Harrow (HROW) Is Up 6.8% After Reaffirming 2026 Revenue Outlook Despite Wider Q1 LossesWhat's Changed - simplywall.st

Harrow Inc. (HROW) Q1 2026 Earnings: Significant EPS Miss Amid Operational ChallengesOperating Margin Analysis - newsline.com

Harrow Inc. Q1 2026 Earnings: Pharmaceutical Firm Misses EPS Estimates by Wide MarginAnalyst Coverage Count - thelegaladvocate.com

Harrow Inc (HROW) Shares Surge 6.8% -- What GF Score of 82 Tells Investors - GuruFocus

Why B.Riley Reduced Harrow, Inc. (HROW) Price Target Despite Long-Term Optimism - Insider Monkey

Harrow: Demand Keeps It Interesting, Valuation Keeps It A Hold - Seeking Alpha

Harrow, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HROW) 2026-05-19 - Seeking Alpha

Harrow director Lauren Silvernail buys $31,000 in company stock By Investing.com - Investing.com Nigeria

Harrow director Adrienne Graves buys $31,070 in company stock By Investing.com - Investing.com Nigeria

Harrow director Lauren Silvernail buys $31,000 in company stock - Investing.com India

Insider Buying: Adrienne Graves Acquires Shares of Harrow Inc (H - GuruFocus

5 Best Small Cap Pharma Stocks to Buy Right Now - Insider Monkey

Harrow director Adrienne Graves buys $31,070 in company stock - Investing.com

Harrow (HROW) director Adrienne Graves buys 1,000 shares at $31.07 - Stock Titan

Harrow (HROW) director purchases 1,000 common shares at $31.00 price - Stock Titan

Harrow projects $71M-$81M Q2 revenue while reaffirming $350M-$365M 2026 outlook - MSN

[Form 4] HARROW, INC. Insider Trading Activity - Stock Titan

Harrow Inc Azioni (HROW) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a HROW